AG
CNST

Algert Global’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Algert Global’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-34,901
Closed -$816K – 573
2021
Q1 		$816K Sell
34,901
-29,988
-46% -$908K 0.26% 140
2020
Q4 		$1.87M Buy
64,889
+21,915
+51% +$552K 0.53% 48
2020
Q3 		$871K Buy
42,974
+17,402
+68% +$425K 0.28% 139
2020
Q2 		$768K Buy
+25,572
New +$921K 0.26% 140

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Algert Global's CNST Position: Q2 2021 in Review

Algert Global sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 34,901 shares — an estimated $816K sold.

Algert Global first reported a position in CNST in Q2 2020 and held it in 4 quarters. The position peaked at $1.87M in Q4 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Algert Global reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Algert Global sold 34,901 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $816K.
  • Algert Global first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 4 quarters.
  • Algert Global's Constellation Pharmaceuticals, Inc. position peaked at $1.87M in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Algert Global's 13F filing for Q2 2021, filed 13 Aug 2021.